AAAAAA
Results:
1-12
|
Results: 12
Authors:
Lissoni, P
Bucovec, R
Bonfanti, A
Giani, L
Mandelli, A
Roselli, MG
Rovelli, F
Fumagalli, L
Citation: P. Lissoni et al., Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia, J PINEAL R, 30(2), 2001, pp. 123-126
Authors:
Lissoni, P
Malugani, F
Bonfanti, A
Bucovec, R
Secondino, S
Brivio, F
Ferrari-Bravo, A
Ferrante, R
Vigore, L
Rovelli, F
Mandala, M
Viviani, S
Fumagalli, L
Gardani, GS
Citation: P. Lissoni et al., Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1, J BIOL REG, 15(2), 2001, pp. 140-144
Authors:
Lissoni, P
Rovelli, F
Vellani, D
Malugani, F
Bucovec, R
Chapovalenko, L
Fumagalli, E
Gardani, G
Citation: P. Lissoni et al., Stimulation of IL-18 secretion by IL-2 in patients with advanced cancer, INT J B MAR, 16(2), 2001, pp. 146-147
Authors:
Lissoni, P
Rovelli, F
Baiocco, N
Tangini, G
Fumagalli, L
Citation: P. Lissoni et al., A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic cell carcinoma progressing on interleukin-2 alone, ANTICANC R, 21(1B), 2001, pp. 777-779
Authors:
Lissoni, P
Brivio, F
Rovelli, F
Fumagalli, G
Malugani, F
Vaghi, N
Secondino, S
Bucovec, R
Gardani, GS
Citation: P. Lissoni et al., Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease, J BIOL REG, 14(4), 2000, pp. 275-277
Authors:
Bonfanti, A
Lissoni, P
Bucovec, R
Rovelli, F
Brivio, F
Fumagalli, L
Citation: A. Bonfanti et al., Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer, INT J B MAR, 15(2), 2000, pp. 161-164
Authors:
Lissoni, P
Mandala, M
Rovelli, F
Casu, M
Rocco, F
Tancini, G
Scardino, E
Citation: P. Lissoni et al., Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia, EUR UROL, 37(5), 2000, pp. 569-572
Authors:
Mandala, M
Lissoni, P
Ardizzoia, A
Barni, S
Rovelli, F
Confalonieri, G
Malugani, F
Moro, C
Fumagalli, G
Giani, L
Tancini, G
Citation: M. Mandala et al., Endocrinological study of the dopaminergic regulation of prolactin releasein metastatic breast cancer, TUMORI, 85(6), 1999, pp. 494-497
Authors:
Fumagalli, L
Lissoni, P
Di Felice, G
Meregalli, S
Valsuani, G
Mengo, S
Rovelli, F
Citation: L. Fumagalli et al., Pretreatment serum markers and lymphocyte response to interleukin-2 therapy, BR J CANC, 80(3-4), 1999, pp. 407-411
Authors:
Lissoni, P
Laudon, M
Barni, S
Brivio, F
Tisi, E
Rovelli, F
Chatikhine, V
Fumagalli, L
Maestroni, GJM
Conti, A
Tancini, G
Citation: P. Lissoni et al., Long-term results of cancer immunotherapy with subcutaneous low-dose interleukin-2 plus melatonin, INT J IMM T, 14(3), 1998, pp. 169-174
Authors:
Franzosi, MG
Santoro, E
De Vita, C
Geraci, E
Lotto, A
Maggioni, AP
Mauri, F
Rovelli, F
Santoro, L
Tavazzi, L
Tognoni, G
Citation: Mg. Franzosi et al., Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction - Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto-1 study, CIRCULATION, 98(24), 1998, pp. 2659-2665
Authors:
Lissoni, P
Fumagalli, L
Rovelli, F
Brivio, F
Di Felice, G
Majorca, F
Citation: P. Lissoni et al., In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients, BR J CANC, 77(11), 1998, pp. 1957-1960
Risultati:
1-12
|